Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD and Safety of HSK3486 (Ciprofol) in Renal Impairment
NCT04142970Phase 1Completed
- Sponsor
- Sichuan Haisco Pharmaceutical Co., Ltd.
- Start
- Jan 2020
- Primary completion
- Aug 2020
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1, open-label trial of ciprofol in general anesthesia and Procedural sedation (PS) (3 arms), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd. Primary endpoints: Peak concentration and Area under the concentration-time curve. Started Jan 2020; status: completed.
02
Drugs
ciprofol
03
Conditions
general anesthesiaProcedural sedation (PS)
Beyond the preview
Go deeper on NCT04142970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04142970.